TFSA Picks: 1 Healthcare Value Stock with Significant Growth Opportunities

The extent of value-added services provided by Viemed Healthcare Inc. (TSX:VMD)(NASDAQ:VMD) should add significant intrinsic company value over the long-term.

| More on:

Viemed Healthcare (TSX:VMD)(NASDAQ:VMD) is a participating medicare durable medical equipment supplier that provides post-acute respiratory care services in the United States. The company operates through two wholly-owned subsidiaries, Sleep Management and Home Sleep.

Viemed’s primary objective is to solidify the company’s position as the largest independent leader in home therapy of patients suffering from respiratory diseases that require a high level of service. The company’s programs are designed specifically for payors to gain the ability to treat patients in the home for less total cost and with a superior quality of care.

Organic growth model

The services of the company’s subsidiaries include respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, and respiratory equipment rentals. Viemed adopts an organic growth model whereby expansion is effectuated through existing service areas as well as in new regions through a cost-efficient launch that reduces location expenses.

Viemed employs more respiratory therapists than any other independent provider in the United States. By focusing overhead costs to personnel that service the patient rather than physical location costs, Viemed anticipates efficiently scaling the company’s business in regions that are currently not being effectively serviced.

Significant growth opportunities

The continued trend of servicing patients in the home rather than in hospitals is aligned with Viemed’s vision, and management anticipates that it will continue to offer growth opportunities for Viemed. Viemed expects to continue to be a solution to the rising health costs in the United States by offering more cost-effective home based solutions while increasing the quality of life for patients fighting serious respiratory diseases.

Revenue from ventilator products represented approximately 87% and 92% of total revenues. Viemed’s management believes that the company’s subsidiaries are poised for organic growth moving forward. The company focuses on disease management and improving the quality of life for respiratory patients through clinical excellence, education and technology.

Variety of service offerings

Viemed’s service offerings are based on effective home treatment with respiratory care practitioners providing therapy and counseling to patients at homes using cutting-edge technology. The company’s home sleep division focuses on providing in-home sleep testing for sleep apnea sufferers.

Further, Viemed is one of the largest independent non-invasive ventilator provider in the United States with a service coverage area of 24 states in the United States and prospects to grow. The company’s respiratory disease management service aims at improving quality of life and reducing hospital re-admissions by using proven methodology and leading technologies such as counseling on proper diet, activity level, smoking cessation and inhaler use.

Value-added services

Viemed sources hardware from vendors and pairs them with industry leading respiratory therapy. The company’s neuromuscular care service is focused on helping neuromuscular patients to breathe more comfortably while living an active, healthier life, and uses respiratory therapy treatments which can lessen the effort required to breathe.

Also, the company’s oxygen therapy service provides the patient with extra oxygen, which is sometimes used to manage certain chronic health problems. Overall, the extent of value-added services provided by Viemed should add significant intrinsic company value over the long term.

Fool contributor Nikhil Kumar has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Viemed Healthcare Inc.

More on Investing

Young adult concentrates on laptop screen
Stocks for Beginners

Beginner Investors: 6 Top Canadian Stocks for 2026

Want to start investing in Canadian stocks in 2026? Here are six quality stocks for a new investor's portfolio.

Read more »

woman checks off all the boxes
Stocks for Beginners

Buying a Stock for the First Time? Review Buffett’s Non-Negotiable Checklist

Newbie investors can benefit by checking Warren Buffett’s non-negotiable checklist before buying stocks.

Read more »

Young Boy with Jet Pack Dreams of Flying
Investing

Should You Stick With Air Canada Stock Through 2030?

Air Canada's stock price is rallying today, but there are many risks lurking in the background to watch out for.

Read more »

ways to boost income
Dividend Stocks

3 Reasons I’m Never Selling This Dividend Stock

Here's why this high-quality dividend stock with a yield of more than 6.8% is a stock I plan to hold…

Read more »

Soundhound AI is a leader in voice recognition software
Dividend Stocks

Outlook for Rogers Communications Stock in 2026

Rogers Communications might be one of the best-known stocks on the TSX, but how is it positioned for 2026?

Read more »

Women's fashion boutique Aritzia is a top stock to buy in September 2022.
Investing

Aritzia Stock: Is it Time to Back Up the Truck After a 270% Gain in 2 Years?

Aritzia (TSX:ATZ) is shaping up to be one of the hottest TSX stocks out there, but it's getting pricey.

Read more »

top TSX stocks to buy
Investing

Top Canadian Stocks to Buy With $2,000 in 2026

Supported by strong underlying businesses, solid returns, and attractive growth prospects, these three Canadian stocks appear to be compelling buys…

Read more »

chip glows with a blue AI
Tech Stocks

Outlook for Celestica Stock in 2026

Celestica (CLS) stock is riding the massive AI wave. Is it too late to buy this soaring Canadian tech stock…

Read more »